Tag:
biomarker deals
Latest Headlines
Latest Headlines
Regulus sets off whirlwind of activity
In a busy week, Regulus Therapeutics signed a microRNA biomarker pact with Biogen Idec ($BIIB), announced an miRNA therapeutics deal with AstraZeneca ($AZN) and filed an IPO of $57.5 million.
Pfizer, Exonhit partner on Alzheimer's biomarkers
Paris-based biotech Exonhit Therapeutics has established a research pact with Pfizer to discover Alzheimer's disease biomarkers via a pilot study. The study will use Exonhit's Genome-Wide SpliceArray
Drug giant Merck, biotech giant BGI team up to discover biomarkers
BGI will take all that sequencing power it possesses as the world's largest genomics center--the same power that helped crack the German E. coli case --and put it together with Merck ($MRK), one of
Protagen, Biogen Idec partner on MS biomarkers
BioArray News reports on Dortmund, Germany-based Protagen's continuing mission to partner with other companies on biomarker discovery. The latest is a deal with Biogen Idec to discover biomarkers for
Caliper, HistoRx get together for imaging, analysis
Caliper Life Sciences and HistoRx are pooling their resources to produce a new way of imaging and analyzing tissue to measure proteins based on immuno-fluorescence. According to a release, the
Nuclea, Boston Medical team up to find cancer biomarkers
Nuclea Biotechnologies, based in Pittsfield, MA, is partnering with the Boston Medical Center to research and develop biomarkers for patients with breast and prostate cancers. Under the partnership,
